Evidence map›Paper›PMID 40035824›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes.

Raad Saad Luty, Adeeb Ahmed Al-Zubaidy, Arif Sami Malik, Hayder Ridha-Salman, Alaa Hamza Abbas

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raad Saad LutyDepartment of Dental Surgery, College of Dentistry, University of Basrah, Basrah, Iraq.
Adeeb Ahmed Al-ZubaidyCollege of Medicine, Department of Pharmacology, University of Warith Al-Anbiyaa, Karbala, Iraq.
Arif Sami MalikCollege of Medicine, Department of Medicine, Al-Nahrain University, Baghdad, Iraq.
Hayder Ridha-SalmanCollege of Pharmacy, Department of Pharmacology, Al-Mustaqbal University, Hillah, 5001, Babylon, Iraq. hayder80.ridha@gmail.com.
Alaa Hamza AbbasCollege of Pharmacy, Al-Mustaqbal University, Hillah, 51001, Babylon, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) represents the primary cause of chronic kidney disease (CKD) worldwide. Orientin is a natural bioactive flavonoid with profound immunomodulatory, anti-inflammatory, and antioxidative effects. This study aimed to investigate the nephroprotective effect of orientin on rat prototypes of high-fat diet (HFD) and streptozotocin (STZ)-induced DN. 75 male rats were divided into 5 groups of 15 rats each. Rats were fed a HFD for 4 weeks, injected with a single dose of STZ 30 mg/kg, and continued on HFD for 15 weeks. Orientin was administered daily at 40 mg/kg for 15 weeks. The diabetic group reported substantially greater fasting blood glucose, HbA1c, and renal function measures than normal controls, as well as notable kidney histological abnormalities such as interstitial inflammation, glomerular shrinkage, and tubular necrosis. Additionally, the diabetic group showed dramatically greater amounts of IL-1β, IL-6, TNF-α, TGF-β1, MDA, and a much lower level of GSH than the control group. However, orientin had no effect on the glycaemic parameters, but it dramatically reduced blood creatinine levels, prevented the development of histopathological irregularities, and minimized the renal concentrations of inflammatory and oxidative markers. Orientin may be a promising natural medication for improving diabetic nephropathy thanks to its robust anti-inflammatory and anti-proliferative properties.

Indexed as

AntioxidantsDiabetes Mellitus, ExperimentalDiabetic NephropathiesFlavonoidsGlucosidesAnimalsAnti-Inflammatory AgentsBlood GlucoseCytokinesDiet, High-FatGlycated HemoglobinKidneyMaleRatsRats, Sprague-DawleyStreptozocinAnti-Inflammatory AgentsAntioxidantsBlood GlucoseCytokinesFlavonoidsGlucosidesGlycated HemoglobinorientinStreptozocinDiabetes mellitusDiabetic nephropathyFlavonoidsOrientinOxidative stress

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.